Back to top

LACOG 0122 – RADIANT

  /    /  LACOG 0122 – RADIANT

Extreme hypofractionation radiotherapy in patients with breast cancer in Brazil: retrospective cohort study

Type of Study: Epidemiological

Sponsor / Support: LACOG

Primary Objectives: To evaluate the effectiveness of the extreme hypofractionation scheme, in 5 fractions of 5.2 Gy, in women with breast cancer.

Design: This is an observational, retrospective cohort study.

Sample Size: 363 – 500 patients

Principal Investigator: Gustavo Nader Marta

Countries LATAM: Brazil

Clinicaltrials.gov Identifier: NCT05776147

The study is open to patients participation in the following research sites:

ICC - Instituto do Câncer do Ceará / Fortaleza / CE / Brazil

A.C. Camargo Cancer Center / São Paulo / SP / Brazil

Oncominas - Clínica de Oncologia no Sul de Minas / Pouso Alegre / MG / Brazil

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP / Ribeirão Preto / SP / Brazil

Hospital Sírio-Libanês / São Paulo / SP / Brazil

BP - A Beneficência Portuguesa de São Paulo / São Paulo / SP / Brazil

HAOC - Hospital Alemão Oswaldo Cruz / São Paulo / SP / Brazil

Instituto COI - Clínicas Oncológicas Integradas (Instituto Américas RJ) / Rio de Janeiro / RJ / Brazil